Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities    
Net loss $ (3,511,980) $ (4,841,591)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 20,622 20,000
Amortization of debt discount 53,353 31,772
Debt conversion expense 355,985
Stock-based compensation 107,315 611,522
Non-cash consulting services 24,000
Straight-line rent adjustment (621) (196)
Changes in operating assets and liabilities, net of effects of disposition:    
Accounts receivable 15,779 (94,779)
Other receivables 77,351 (23,369)
Prepaid expenses 145,464 224,416
Inventory 88,219 (164,867)
Accounts payable 492,787 43,106
Accounts payable to related parties 57,184 671
Interest payable 11,487
Unearned revenue (1,048)
Accrued payroll 124,817
Accrued liabilities 179,435 (84,800)
Net Cash Used in Operating Activities (2,115,836) (3,922,130)
Cash Flows from Investing Activities    
Payment received from Streamline note receivable 150,000
Expenditures for property and equipment (14,808)
Net Cash Provided by (Used in) Investing Activities 150,000 (14,808)
Cash Flows from Financing Activities    
Principal payments under note payable obligations (215,730) (112,342)
Proceeds from issuance of common stock and preferred stock, net of offering costs 901,291 3,838,671
Proceeds from issuance of warrants, net of offering costs 238,855 1,248,575
Proceeds from issuance of convertible debt 74,354
Proceeds from issuance of short term loan 950,000
Net Cash Provided by Financing Activities 1,948,770 4,974,904
Net Increase/(Decrease) in Cash (17,066) 1,037,966
Cash - Beginning of period 245,026 892,814
Cash - End of period 227,960 1,930,780
Supplementary Cash Flow Information    
Cash paid for interest 4,768 6,130
Non-cash investing and financing activities    
Financing agreement for insurance policy 74,672 66,895
Conversion of convertible note and accrued interest to common stock 101,194 718,079
Conversion of short-term loan to common stock 126,720
Conversion of short-term loan to preferred stock and warrants 100,000
Issuance of warrants for conversion of notes 305,201
Common stock issued for board fees 240,000
Issuance of common stock for preferred stock conversion 1,274 931
Issuance of common stock warrants for placement agent fees 304,183
Issuance of common stock for consideration of cancellation of warrants 208,000
Issuance of warrants for promissory note 25,646
Dividends accrued 19,271
Issuance of warrants for Bridge Loan $ 244,576